Search

Device & Insulin Compatibility: Interactive Tool and Matrix

U.S. FDA-labeled/cleared insulin compatibility for automated insulin delivery (AID) systems, pumps, patch pumps and connected pens.
Written by: danatech from ADCES clinical staff, June 2026

 

danatech's Interactive Tool

Compatibility Matrix

danatech · Printable reference

Insulin & Device Compatibility — At-a-Glance Chart

Which U.S.-labeled insulins are listed for use with common insulin pumps, automated insulin delivery (AID) systems, patch pumps and connected pens. Print this page for a desk reference, or use the interactive lookup tool above for substitution-risk guidance and bidirectional search.

Reflects U.S. labeling current as of June 2026

 

✓ Listed in current labeling
! Conflicting or unconfirmed — verify before relying on it
– Not listed

Pumps, AID Systems & Patch Pumps

All insulins below are U-100 rapid-acting unless noted. Compatibility is device-model-specific — an insulin listed for one device is not automatically listed for another from the same manufacturer.

Rapid-acting insulin compatibility by pump / AID system
DeviceNovoLogFiaspHumalogAdmelogLyumjevApidraKirsty
Tandem t:slim X2 / Control-IQ+✓–✓–✓––
Tandem Mobi✓–✓––1––
Medtronic MiniMed 780G✓✓✓✓✓––
MiniMed Flex✓✓✓✓✓––
Beta Bionics iLet✓✓2✓–––!3
Sequel twiist ✓–✓––––
Omnipod 5✓–✓✓––✓
Omnipod DASH✓✓✓✓✓✓4–
Omnipod GO✓✓✓✓✓––
CeQur Simplicity✓–✓––––
V-Go✓–✓––––

1 Tandem Mobi does not inherit the t:slim X2's Lyumjev clearance — listed for Humalog and NovoLog only.

2 Fiasp is listed for iLet only in the prefilled Fiasp PumpCart cartridge, not from a vial.

3 Kirsty / iLet: named in the iLet User Guide fill instructions but not on the Beta Bionics safety/compatible-drugs page. Confirm against the current User Guide before relying on it.

4 Apidra wear time with Omnipod DASH is up to 48 hours, versus 72 hours for the other listed insulins.

Connected Pens & Caps

Smart pens and pen caps meter insulin differently than pumps. Compatibility is tied to the cartridge or prefilled pen format, not the molecule alone.

Rapid-acting insulin compatibility — connected pens
DeviceNovoLogFiaspHumalogAdmelogLyumjevApidra
Medtronic InPen (also MiniMed Go)✓✓✓––5–
Bigfoot Unity — White Cap✓✓✓✓✓✓

5 InPen has no compatible 3.0 mL cartridge format for Lyumjev — this is a packaging gap, not a clinical incompatibility.

Bigfoot Unity uses pen-device-specific caps (KwikPen, FlexPen, FlexTouch, SoloStar) and also covers U-200/U-300 concentration pens and unbranded biologic equivalents not shown in this simplified chart — confirm the exact pen on Bigfoot's current compatible-insulins list.

Long-Acting / Basal Insulin

Only one connected device in this reference meters basal insulin.

Long-acting insulin compatibility — connected pen caps
DeviceLantusBasaglarToujeoTresiba
Bigfoot Unity — Black Cap✓✓✓✓

Before You Prescribe, Fill, or Train

  • Confirm the exact device model. Compatibility is tied to the specific device, not the manufacturer or brand family.
  • Confirm insulin concentration. All devices above are intended for U-100 insulin unless noted. U-200, U-300, and U-500 insulins should not be substituted unless the device labeling specifically allows it.
  • Confirm the insulin name and formulation. Some devices list specific branded products, biosimilars, or cartridge formats — not all insulin aspart or insulin lispro products are automatically interchangeable for device use.
  • Watch for biosimilar substitution. Kirsty is the only interchangeable rapid-acting biosimilar in the U.S. — a pharmacist may substitute it for NovoLog without prescriber sign-off, subject to state law. A device's product list not naming a biosimilar doesn't automatically make it off-label; check the device User Guide and the insulin's prescribing information (section 2.2).
  • Use shared decision-making. Insulin and device choices should weigh clinical needs, safety, cost and coverage, access, dexterity, vision, technology comfort, and the preferences of the person using the device.
Device labeling and insulin compatibility change over time. This is a point-in-time reference, not clinical decision support. Always verify against the current instructions for use, safety information, or prescribing information before making clinical decisions.
Reflects U.S. labeling current as of June 2026 · danatech · build 2026-06-17

References by device

  1. Tandem t:slim X2 (Control-IQ+) — NovoLog, Humalog, Lyumjev U-100; Lyumjev cleared Sept 2025.Manufacturer / FDA
    Tandem t:slim X2 indications · Lyumjev clearance announcement
  2. Tandem Mobi — NovoLog, Humalog U-100; Lyumjev not yet cleared for this model.Manufacturer
    Tandem Mobi product page
  3. Medtronic MiniMed 780G — NovoLog, Fiasp, Humalog, Lyumjev U-100; Fiasp & Lyumjev cleared Jan 2026.Manufacturer / FDA
    780G expanded-label clearance (Jan 2026)
  4. Beta Bionics iLet — NovoLog, Humalog, Fiasp PumpCart U-100.Manufacturer
    Beta Bionics iLet
  5. twiist (Sequel Med Tech) — Humalog, NovoLog U-100 only.Manufacturer / FDA
    twiist FAQ (insulin compatibility) · FDA 510(k) clearance
  6. Omnipod 5 (AID) — NovoLog, Humalog, Admelog, Kirsty U-100 (narrower than DASH).Manufacturer / FDA
    Omnipod Important Safety Information · Omnipod 5 indications
  7. Omnipod DASH — NovoLog, Fiasp, Humalog, Admelog, Lyumjev, Apidra U-100 (Apidra up to 48 hrs).Manufacturer / FDA
    Omnipod Important Safety Information · FDA 510(k) summary (K191679)
  8. Omnipod GO (basal-only, T2D) — NovoLog, Fiasp, Humalog, Admelog, Lyumjev U-100.Manufacturer / FDA
    FDA 510(k) summary (K223372)
  9. Medtronic InPen — Humalog, NovoLog, Fiasp U-100 3 mL cartridges.Manufacturer
    Medtronic InPen
Manufacturer / FDA = manufacturer labeling and/or FDA 510(k) clearance   Manufacturer = manufacturer product/labeling page where a standalone FDA summary was not separately cited. All device insulin clearances should be confirmed against the current IFU.

Diabetes Tech Skills Supported

✓ Device Selection

✓ Product Knowledge

✓ Safe Technology Use

✓ Clinical Troubleshooting

Why This Matters

  • Helps select appropriate insulin-device combinations

  • Minimizes potential compatibility-related therapy issues

  • Supports safe device initiation

  • Helps troubleshoot unexpected device performance

The Danatech Digest

Join 25,000+ professionals who get our latest diabetes technology updates

DISCLAIMERS: 

This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your diabetes care and education specialist or health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. To find a diabetes care and education specialist near you, visit the ADCES finder tool.

ADCES and danatech curate product specifics and periodically review them for accuracy and relevance. As a result, the information may or may not be the most recent. We recommend visiting the manufacturer's website for the latest details if you have any questions.

danatech is Made Possible by Grant Funding and Industry Sponsorship